In ALS patients, circulating levels of C1q, C3, C4, C5a, and C5b-9 were found to be elevated, indicating both increased capacity and recruitment of the classical and terminal complement pathways [82, 209]. This evidence concerns the gene C5 and amyotrophic lateral sclerosis.